Challenge: Existing methods for natural language processing are labor-intensive and skill-dependent . Currently, most biomedical natural language tasks focus on English documents .
Approach: They introduce a BERT benchmark to facilitate the research of PharmaCoNER task . they evaluate two baselines based on Multilingual BERT and BioBERT on the corpus .
Outcome: The proposed task is based on multilingual BERT and BioBERT on the PharmaCoNER corpus.

Similar Papers

Biomedical Named Entity Recognition with Multilingual BERT (D19-57)

Copied to clipboard

Challenge: a multilingual model is not specifically tailored to either the language nor the application domain.
Approach: They propose a CRF-based baseline approach and multilingual BERT to the task . they achieve an F-score of 88% on the development data and 87% on the test set with BERT .
Outcome: The proposed model achieves an F score of 88% on the development data and 87% on the test set with BERT.
Named Entity Recognition for Chinese biomedical patents (2020.coling-main)

Copied to clipboard

Challenge: Existing attempts to address NER for Chinese biomedical texts have been limited due to the amount of Chinese biomedicine discoveries being patented.
Approach: They train and evaluate Chinese biomedical patents NER models based on BERT . their model is optimized for Chinese bio-patent data and scored an F1 .
Outcome: The proposed model achieves an F1 score of 0.540.15 for Chinese biomedical patent data.
Where do LLMs currently stand on biomedical NER in both clean and noisy settings ? (2026.findings-eacl)

Copied to clipboard

Challenge: despite advances in medicine, many diseases remain without effective treatments . clinical meta-analysis is essential for drug discovery and clinical research .
Approach: They investigate the performance of large language models (LLMs) on biomedical NER tasks . findings suggest LLMs exhibit a notable degree of robustness to noise .
Outcome: The proposed models are closing the performance gap with BERT-based models and demonstrate particular strengths in low-data settings.
Named Entity Recognition Under Domain Shift via Metric Learning for Life Sciences (2024.naacl-long)

Copied to clipboard

Challenge: Existing models for named entity recognition fail in scientific domains such as biomedicine and chemistry.
Approach: They propose a model to transfer knowledge from the biomedical domain to the target domain . they use pseudo labeling and contrastive learning to enhance discrimination .
Outcome: The proposed model outperforms baseline models by up to 5% . the proposed model is based on a biomedical domain model and a chemical domain model .
What Matters for Neural Cross-Lingual Named Entity Recognition: An Empirical Analysis (D19-1)

Copied to clipboard

Challenge: Named entity recognition models are challenging for languages with little training data.
Approach: They propose a simple and efficient neural architecture for cross-lingual named entity recognition models.
Outcome: The proposed model achieves competitive performance with the state-of-the-art on two transferable factors: sequential order and multilingual embedding.
OpenBioNER: Lightweight Open-Domain Biomedical Named Entity Recognition Through Entity Type Description (2025.findings-naacl)

Copied to clipboard

Challenge: Biomedical Named Entity Recognition (BioNER) is a computationally expensive and limited tool . specialized 7B NER LLMs and GPT-4o can't match textual spans with entity types .
Approach: They propose a lightweight BERT-based cross-encoder architecture that can identify any biomedical entity using only its description.
Outcome: The proposed system outperforms existing models that match textual spans with entity types rather than descriptions on biomedical benchmarks.
A Deep Learning-Based System for PharmaCoNER (D19-57)

Copied to clipboard

Challenge: Efficient access to mentions of clinical entities is very important for using clinical text.
Approach: They developed a pipeline system based on deep learning methods for this shared task . it achieves a micro-average F1-score of 0.9105 on track 1 and a mini-average LSTM score of 0.8391 on track 2 .
Outcome: The proposed system achieves a micro-average F1-score of 0.9105 on track 1 and a mini-average score of 0.8391 on track 2.
PharmaCoNER: Pharmacological Substances, Compounds and proteins Named Entity Recognition track (D19-57)

Copied to clipboard

Challenge: Biomedical text mining is one of the most prolific application domains of natural language processing technologies.
Approach: They propose to share a task on detecting drug and chemical entities in medical documents in Spanish with other languages to improve access to biomedical text mining.
Outcome: The first task on detecting drug and chemical entities in Spanish medical documents yielded competitive results with F-measures above 0.91.
Learning Domain-Specialised Representations for Cross-Lingual Biomedical Entity Linking (2021.acl-short)

Copied to clipboard

Challenge: Existing work on transferring domain-specific knowledge from a pretraining model to a resource-poor language is limited to English . a novel cross-lingual biomedical entity linking task is proposed to improve this capability.
Approach: They propose a cross-lingual biomedical entity linking task and establish a new benchmark spanning 10 typologically diverse languages.
Outcome: The proposed methods yield consistent gains across all target languages, sometimes up to 20 Precision@1 points, without any in-domain knowledge in the target language and without any parallel data.
Incorporating medical knowledge in BERT for clinical relation extraction (2021.emnlp-main)

Copied to clipboard

Challenge: Pre-trained language models (PLMs) are used for diverse NLP tasks such as Information Extraction, Sentiment Analysis and Question/Answering.
Approach: They propose to add medical knowledge to pre-trained language models to facilitate clinical relation extraction using a large text corpus.
Outcome: The proposed model outperforms the state-of-the-art systems on the benchmark i2b2/VA 2010 clinical relation extraction dataset.

What is GenGO?

GenGO is an NLP powered publication search system. It currenctly indexes 30k+ papers from ACL Anthology, and implements multi-aspect summarization, semantic search, and more!

Information

About
Limitations